Market Cap
$173.90M
Shares Outstanding
12.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 20, 2014
Round Lot
100
Locale
US
Day Open
$13.58
Day High
$13.58
Day Low
$13.12
Volume
79.0K
VWAP
$13.33
Prev Close
$13.47
Transactions
--
Acc. Volume
--
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
MediWound Ltd. (MDWD) closed the 2026-09-16 session at $13.22, down 1.86% versus the previous close (-0.25). The stock opened at $13.58 and traded between $13.12 and $13.58 during that session. Session trading volume was 79K shares. The volume-weighted average price (VWAP) is $13.33.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
MediWound Ltd. has a market capitalization of $173.9 million. MDWD is listed on the XNAS exchange. The company employs approximately 121 people. The recorded listing date is 2014-03-20.
On this page you can find market MDWD stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.